| Literature DB >> 32700105 |
Sirio Cocozza1, Simona Schiavi2, Giuseppe Pontillo3, Matteo Battocchio2, Eleonora Riccio4, Simona Caccavallo5, Camilla Russo1, Teodolinda Di Risi5,6, Antonio Pisani5, Alessandro Daducci2, Arturo Brunetti1.
Abstract
PURPOSE: Recent evidences have suggested the possible presence of an involvement of the extrapyramidal system in Fabry disease (FD), a rare X-linked lysosomal storage disorder. We aimed to investigate the microstructural integrity of the main tracts of the cortico-striatal-thalamo-cortical loop in FD patients.Entities:
Keywords: Brain; Fabry disease; Magnetic resonance imaging; Tractometry
Mesh:
Year: 2020 PMID: 32700105 PMCID: PMC7568710 DOI: 10.1007/s00234-020-02497-7
Source DB: PubMed Journal: Neuroradiology ISSN: 0028-3940 Impact factor: 2.804
Fig. 1Image showing the reconstructed tracts in a 29-year-old female healthy control. From left to right, the cortico-spinal, the cortico-striatal and thalamo-cortical tracts (red indicates the left side, blue the right side), with the green and yellow areas indicating the left and right precentral gyri, respectively. Finally, the dark blue and purple regions of interests represent the left striatum (as the sum of caudate nucleus and putamen) and the thalamus, while in orange and light blue are displayed the contralateral regions
Complete list of the demographic and clinical information of the included population
| HC | FD | |
|---|---|---|
| Age (mean ± SD) | 42.3 ± 16.3 | 42.3 ± 13.1 |
| Sex (M/F) | 28/21 | 19/28 |
| ERT | n.a. | 35/47 |
| ERT duration (mean ± SD) | n.a. | 33.1 ± 30.6 |
| Cephalalgia | n.a. | 6/47 |
| Acroparesthesia | n.a. | 7/47 |
| Hypertension | n.a. | 12/47 |
| Diabetes | n.a. | 1/47 |
| Arrhythmia | n.a. | 3/47 |
| Left ventricular hypertrophy | n.a. | 23/47 |
| Renal failure | n.a. | 12/47 |
| Proteinuria | n.a. | 18/47 |
Subjects demographic and clinical variables of all subjects included in the study. Age is expressed in years, while ERT duration is expressed in months
FD Fabry disease, SD standard deviation, ERT enzyme replacement therapy, n.a. not applicable
Results of the between groups analyses investigating the global WM microstructure
| HC | FD | ||
|---|---|---|---|
| FA | 0.238 ± 0.011 | 0.233 ± 0.012 | |
| MD (10−3 mm2/s) | 1.032 ± 0.082 | 1.020 ± 0.086 | 0.565 |
| AD (10−3 mm2/s) | 1.237 ± 0.083 | 1.122 ± 0.089 | 0.331 |
| RD (10−3 mm2/s) | 0.929 ± 0.082 | 0.921 ± 0.086 | 0.711 |
Mean values and standard deviations of the diffusion metrics (FA, MD, AD and RD) of the entire WM for the two groups of subjects. In the last column, the p values obtained comparing HC and FD using a GLM with age, sex, and ICV are reported (the significant difference is in italics)
FA fractional anisotropy, MD mean diffusivity, AD axial diffusivity, RD radial diffusivity, HC healthy controls, FD Fabry disease, GLM general linear model, ICV intracranial volume
Fig. 2Box and whiskers plot showing the differences in terms of mean microstructural values along the entire white matter in Fabry patients compared with healthy controls. Asterisk indicates significant differences between the two groups
Results of the between groups analyses investigating WM microstructure along the investigated tracts
| Diffusion metric | Tract | Side | HC | FD | |
|---|---|---|---|---|---|
| FA | PrCG-striatum | R | 0.413 ± 0.025 | 0.399 ± 0.028 | 0.337 |
| L | 0.434 ± 0.024 | 0.412 ± 0.023 | |||
| Thalamus-PrCG | R | 0.438 ± 0.027 | 0.425 ± 0.028 | 0.482 | |
| L | 0.462 ± 0.025 | 0.445 ± 0.025 | 0.183 | ||
| CST | R | 0.499 ± 0.021 | 0.488 ± 0.022 | 0.277 | |
| L | 0.529 ± 0.021 | 0.510 ± 0.025 | |||
| MD (10−3 mm2/s) | PrCG-striatum | R | 0.723 ± 0.027 | 0.728 ± 0.034 | 0.162 |
| L | 0.668 ± 0.019 | 0.685 ± 0.029 | |||
| Thalamus-PrCG | R | 0.720 ± 0.024 | 0.724 ± 0.032 | 0.222 | |
| L | 0.669 ± 0.018 | 0.683 ± 0.024 | |||
| CST | R | 0.749 ± 0.025 | 0.764 ± 0.026 | ||
| L | 0.718 ± 0.026 | 0.740 ± 0.026 | |||
| AD (10−3 mm2/s) | PrCG-striatum | R | 1.065 ± 0.034 | 1.059 ± 0.030 | 0.785 |
| L | 1.001 ± 0.037 | 1.006 ± 0.035 | 0.092 | ||
| Thalamus-PrCG | R | 1.087 ± 0.035 | 1.080 ± 0.029 | 0.813 | |
| L | 1.030 ± 0.035 | 1.036 ± 0.030 | 0.089 | ||
| CST | R | 1.202 ± 0.037 | 1.209 ± 0.034 | 0.307 | |
| L | 1.190 ± 0.044 | 1.200 ± 0.037 | 0.198 | ||
| RD (10−3 mm2/s) | PrCG-striatum | R | 0.551 ± 0.030 | 0.563 ± 0.040 | 0.098 |
| L | 0.501 ± 0.021 | 0.525 ± 0.038 | |||
| Thalamus-PrCG | R | 0.536 ± 0.029 | 0.547 ± 0.039 | 0.169 | |
| L | 0.489 ± 0.021 | 0.507 ± 0.031 | |||
| CST | R | 0.523 ± 0.027 | 0.541 ± 0.033 | ||
| L | 0.483 ± 0.026 | 0.510 ± 0.031 |
Mean values and standard deviations of the diffusion metrics (FA, MD, AD and RD) of the three WM tracts (PrCG-striatum, thalamus-PrCG, and CST) for the two groups of subjects. The p values obtained comparing HC and FD using a GLM with age, sex, ICV, and mean values of the metric in the entire WM are reported in the last column (significant differences are in italics)
FA fractional anisotropy, MD mean diffusivity, AD axial diffusivity, RD radial diffusivity, HC healthy controls, FD Fabry disease, PrCG precentral gyrus, CST cortico-spinal tract, WM white matter, GLM generalized linear model, ICV intracranial volume
Fig. 3Box and whiskers plot showing the results of the tractometry analyses, with mean diffusion metrics along the evaluated tracts in Fabry patients compared with healthy controls. Asterisk indicates significant differences between the two groups